Ir para o conteúdo principal

Escrever uma avaliação PREreview

Joint analysis of human retroelements-linked histone modification profiles reveals quickly evolving molecular processes connected with cancer

Publicado
Servidor
bioRxiv
DOI
10.1101/2025.09.24.677146

Human retroelements (REs), which comprise approximately 40% of the genome, have played a pivotal role in the evolution of key molecular processes, such as placental development, by introducing novel regulatory elements near host gene promoters and enhancers. Despite their genomic abundance and regulatory influence, the functional trajectories of REs remain poorly understood. Here, leveraging ChIP-seq profiles of histone modifications (H3K4me1, H3K4me3, H3K9ac, H3K27ac, H3K27me3, and H3K9me3) from five human cell lines deposited in the ENCODE database, we systematically ranked the regulatory impact of REs across 25,075 human genes. Gene sets enriched for promoter- and enhancer-associated RE-linked regulatory sites were identified. Consensus gene sets across cell lines were found to be associated with pathways involved in cancer progression, specifically chronic myeloid leukemia and small cell lung cancer, as well as with host defense responses to infection with human T-cell lymphotropic virus type 1. These findings provide new insights into recent human evolution and highlight the ongoing influence of selfish genetic elements on genome regulation and disease susceptibility.

Você pode escrever uma avaliação PREreview de Joint analysis of human retroelements-linked histone modification profiles reveals quickly evolving molecular processes connected with cancer. Uma avaliação PREreview é uma avaliação de um preprint e pode variar de algumas frases a um parecer extenso, semelhante a um parecer de revisão por pares realizado por periódicos.

Antes de começar

Vamos pedir que você faça login com seu ORCID iD. Se você não tiver um iD, pode criar um.

O que é um ORCID iD?

Um ORCID iD é um identificador único que diferencia você de outras pessoas com o mesmo nome ou nome semelhante.

Começar agora